A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic
Randomized controlled trials (RCTs) are the best way to find effective and acceptable safe treatments for COVID-19 and any possible future outbreak. However, caution is needed when comparing the number of participants in RCTs with that of patients with COVID-19 treated with compassionate and/or off-...
Main Authors: | Matteo Bassetti, Paolo Pelosi, Chiara Robba, Antonio Vena, Daniele Roberto Giacobbe |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2020-05-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/a-brief-note-on-randomized-controlled-trials-and-compassionate-off-label-use-of-drugs-in-the-early-phases-of-the-covid-19-pandemic |
Similar Items
-
Off-label prescription of drugs at hospital
by: Vicente Arocas Casañ, et al.
Published: (2016-03-01) -
Off-label antineoplastic drugs. An effectiveness and safety study
by: Cristina Arroyo Álvarez, et al.
Published: (2017-05-01) -
Compassionate Drug Use – Time Arising for a New Law in Bulgaria in the Era of COVID-19
by: Nigyar Dzhafer, et al.
Published: (2020-09-01) -
Digital communication can support compassionate leaders and compassionate workplaces
by: Bradshaw, Jeannine
Published: (2013) -
Compassionate Use
by: Pranav Aurora
Published: (2015-05-01)